David A. Dodd
David A. Dodd is Chairman, President, and Chief Executive Officer of GeoVax Labs, Inc., a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer. He brings more than four decades of leadership experience in the biopharmaceutical industry, including corporate strategy, commercialization, and global product development. At GeoVax, he leads the company’s efforts to advance novel vaccine and immuno-oncology platforms addressing significant unmet medical needs.
